HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study.

Saved in:
Bibliographic Details
Title: HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study.
Authors: Chang, Xu1 (AUTHOR), Li, Xinge2 (AUTHOR), Sun, Peng1 (AUTHOR), Li, Zhenfeng1 (AUTHOR), Sun, Pengfei3 (AUTHOR) drsunpengfei@sina.com, Ning, Shangkun4 (AUTHOR) ningskun@163.com
Source: BMC Cancer. 4/16/2024, Vol. 24 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-024-12233-6